Results 71 to 80 of about 580 (130)

Promising Molecular Therapeutic Targets for Drug Development in Rheumatoid Arthritis. [PDF]

J Clin Med
Chung SW.
europepmc   +1 more source

Chronic Spontaneous Urticaria in the Era of Targeted Therapy: From Pathogenic Mechanisms to Precision Medicine. [PDF]

Pharmaceutics
Andrzejczak K, Witkowski W, Górka-Dynysiewicz J, Pawłowicz R, Kopeć A.   +4 more
europepmc   +1 more source

Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination. [PDF]

Inflammopharmacology
Badawi GA, El-Sayed RM, Fawzy MN.
europepmc   +1 more source

Comprehensive Characterization of Bruton's Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures. [PDF]

ACS Pharmacol Transl Sci
Darragh AC, Hanna AM, Lipner JH, King AJ, Servant NB, Jahic M.   +5 more
europepmc   +1 more source

Advancements in research on the cardiovascular toxicity caused by TEC family kinases inhibitors. [PDF]

Front Pharmacol
Zhang Y, Fu H, Kang X, Qiu Z, Yan H, He Q, Yang B, Xu Z, Luo P.   +8 more
europepmc   +1 more source

Beyond relapses: How BTK inhibitors are shaping the future of progressive MS treatment. [PDF]

Neurotherapeutics
Naydovich LR, Orthmann-Murphy JL, Markowitz CE.   +2 more
europepmc   +1 more source

Bruton Tyrosine Kinase in Lesions of Multiple Sclerosis and 3 of Its Models. [PDF]

Neurol Neuroimmunol Neuroinflamm
Li C, Morch MT, Gorter R, Lozinski B, Ghorbani S, Dong Y, Shen YA, Harp C, Zandee S, Klement W, Prat A, Yong VW.   +11 more
europepmc   +1 more source

Potential new targets for rheumatic diseases. [PDF]

EULAR Rheumatol Open
Braun J, Hiepe F.
europepmc   +1 more source

The Art of Sequencing Disease-Modifying Therapies in Multiple Sclerosis. [PDF]

Neurol Neuroimmunol Neuroinflamm
Dersch RS, Pfeuffer S, Bsteh G, Wiendl H.   +3 more
europepmc   +1 more source

Psychiatric comorbidities in multiple sclerosis patients and their relationship with clinical variables: A university hospital sample. [PDF]

Dusunen Adam
Asut G, Iyigundogdu I.
europepmc   +1 more source